Compare Heron Therapeutics Inc (HRTX) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while GraniteShares 2x Long NVDA Daily ETF trades at $31.4. The key difference: GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | NVDL | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.96 | $43.02 |
52-Week Low | $0.39 | $21.76 |
Enterprise Value | $189.36M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
